HEADER MEMBRANE PROTEIN/HYDROLASE 24-OCT-10 3PDS TITLE IRREVERSIBLE AGONIST-BETA2 ADRENOCEPTOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-2 ADRENORECEPTOR, BETA-2 ADRENOCEPTOR; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: ADRB2, ADRB2R, B2AR; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, SIGNALING, BETA ADRENERGIC AGONIST, FUSION PROTEIN, MEMBRANE KEYWDS 2 PROTEIN-HYDROLASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.M.ROSENBAUM,C.ZHANG,J.A.LYONS,R.HOLL,D.ARAGAO,D.H.ARLOW, AUTHOR 2 S.G.F.RASMUSSEN,H.-J.CHOI,B.T.DEVREE,R.K.SUNAHARA,P.S.CHAE, AUTHOR 3 S.H.GELLMAN,R.O.DROR,D.E.SHAW,W.I.WEIS,M.CAFFREY,P.GMEINER, AUTHOR 4 B.K.KOBILKA REVDAT 6 30-OCT-24 3PDS 1 REMARK REVDAT 5 20-SEP-23 3PDS 1 REMARK REVDAT 4 29-MAR-23 3PDS 1 AUTHOR JRNL REMARK SEQADV REVDAT 4 2 1 LINK REVDAT 3 26-JUL-17 3PDS 1 SOURCE REMARK REVDAT 2 09-FEB-11 3PDS 1 JRNL AUTHOR REVDAT 1 12-JAN-11 3PDS 0 JRNL AUTH D.M.ROSENBAUM,C.ZHANG,J.A.LYONS,R.HOLL,D.ARAGAO,D.H.ARLOW, JRNL AUTH 2 S.G.F.RASMUSSEN,H.J.CHOI,B.T.DEVREE,R.K.SUNAHARA,P.S.CHAE, JRNL AUTH 3 S.H.GELLMAN,R.O.DROR,D.E.SHAW,W.I.WEIS,M.CAFFREY,P.GMEINER, JRNL AUTH 4 B.K.KOBILKA JRNL TITL STRUCTURE AND FUNCTION OF AN IRREVERSIBLE AGONIST-BETA(2) JRNL TITL 2 ADRENOCEPTOR COMPLEX JRNL REF NATURE V. 469 236 2011 JRNL REFN ISSN 0028-0836 JRNL PMID 21228876 JRNL DOI 10.1038/NATURE09665 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 9352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.090 REMARK 3 FREE R VALUE TEST SET COUNT : 944 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2496 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2375 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2217 REMARK 3 BIN R VALUE (WORKING SET) : 0.2338 REMARK 3 BIN FREE R VALUE : 0.2663 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 11.18 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 279 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3539 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 81.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.55370 REMARK 3 B22 (A**2) : 14.06710 REMARK 3 B33 (A**2) : -21.62080 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.879 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.847 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.770 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3708 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5041 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1240 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 544 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3672 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 498 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4176 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.89 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.57 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.03 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|29 - A|230 A|263 - A|342 } REMARK 3 ORIGIN FOR THE GROUP (A): 28.5295 7.5758 7.4465 REMARK 3 T TENSOR REMARK 3 T11: -0.2547 T22: 0.0561 REMARK 3 T33: 0.3897 T12: -0.0369 REMARK 3 T13: -0.0143 T23: 0.0208 REMARK 3 L TENSOR REMARK 3 L11: 0.8276 L22: 1.7725 REMARK 3 L33: 0.6525 L12: -0.1286 REMARK 3 L13: 0.1233 L23: -0.0659 REMARK 3 S TENSOR REMARK 3 S11: -0.0385 S12: 0.1642 S13: -0.0835 REMARK 3 S21: 0.0741 S22: 0.1115 S23: 0.5950 REMARK 3 S31: 0.0864 S32: 0.1853 S33: -0.0730 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|1002 - A|1161 } REMARK 3 ORIGIN FOR THE GROUP (A): 71.3516 22.6544 15.9417 REMARK 3 T TENSOR REMARK 3 T11: -0.1642 T22: 0.0921 REMARK 3 T33: -0.0431 T12: -0.0046 REMARK 3 T13: -0.0007 T23: 0.0722 REMARK 3 L TENSOR REMARK 3 L11: 1.7561 L22: 4.1022 REMARK 3 L33: 3.4864 L12: -0.5541 REMARK 3 L13: -0.5257 L23: 2.9168 REMARK 3 S TENSOR REMARK 3 S11: -0.1886 S12: -0.0196 S13: -0.0317 REMARK 3 S21: -0.0028 S22: 0.0146 S23: -0.2817 REMARK 3 S31: -0.0386 S32: 0.1317 S33: 0.1740 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PDS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000062255. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 19 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9385 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.500 REMARK 200 RESOLUTION RANGE LOW (A) : 65.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.20200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.44300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2RH1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26 %(V/V) PEG 400, 200 MM LI2SO4, 4 REMARK 280 %(V/V) DMSO, 3.5 %(V/V) 1,4-BUTANDEDIOL, 100 MM MES PH 6.7, REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 141.22000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.02000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 141.22000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 20.02000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 HIS A 349 REMARK 465 HIS A 350 REMARK 465 HIS A 351 REMARK 465 HIS A 352 REMARK 465 HIS A 353 REMARK 465 HIS A 354 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 29 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 65 46.64 -103.93 REMARK 500 HIS A 172 113.07 -23.44 REMARK 500 TRP A 173 -14.82 -148.49 REMARK 500 PHE A 208 -61.50 -148.55 REMARK 500 ILE A1050 -62.63 -95.17 REMARK 500 ASN A1055 -1.17 65.77 REMARK 500 CYS A 341 80.85 59.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ERC A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1208 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RH1 RELATED DB: PDB REMARK 900 BETA2-ADRENERGIC RECEPTOR WITH INVERSE AGONIST CARAZOLOL BOUND. DBREF 3PDS A 25 230 UNP P07550 ADRB2_HUMAN 25 230 DBREF 3PDS A 1002 263 UNP P00720 LYS_BPT4 2 162 DBREF 3PDS A 264 348 UNP P07550 ADRB2_HUMAN 264 348 SEQADV 3PDS GLN A 27 UNP P07550 GLU 27 CONFLICT SEQADV 3PDS CYS A 93 UNP P07550 HIS 93 ENGINEERED MUTATION SEQADV 3PDS GLU A 187 UNP P07550 ASN 187 ENGINEERED MUTATION SEQADV 3PDS THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 3PDS ALA A 1097 UNP P00720 CYS 97 CONFLICT SEQADV 3PDS HIS A 349 UNP P07550 EXPRESSION TAG SEQADV 3PDS HIS A 350 UNP P07550 EXPRESSION TAG SEQADV 3PDS HIS A 351 UNP P07550 EXPRESSION TAG SEQADV 3PDS HIS A 352 UNP P07550 EXPRESSION TAG SEQADV 3PDS HIS A 353 UNP P07550 EXPRESSION TAG SEQADV 3PDS HIS A 354 UNP P07550 EXPRESSION TAG SEQRES 1 A 458 THR GLN GLN ARG ASP GLU VAL TRP VAL VAL GLY MET GLY SEQRES 2 A 458 ILE VAL MET SER LEU ILE VAL LEU ALA ILE VAL PHE GLY SEQRES 3 A 458 ASN VAL LEU VAL ILE THR ALA ILE ALA LYS PHE GLU ARG SEQRES 4 A 458 LEU GLN THR VAL THR ASN TYR PHE ILE THR SER LEU ALA SEQRES 5 A 458 CYS ALA ASP LEU VAL MET GLY LEU ALA VAL VAL PRO PHE SEQRES 6 A 458 GLY ALA ALA CYS ILE LEU MET LYS MET TRP THR PHE GLY SEQRES 7 A 458 ASN PHE TRP CYS GLU PHE TRP THR SER ILE ASP VAL LEU SEQRES 8 A 458 CYS VAL THR ALA SER ILE GLU THR LEU CYS VAL ILE ALA SEQRES 9 A 458 VAL ASP ARG TYR PHE ALA ILE THR SER PRO PHE LYS TYR SEQRES 10 A 458 GLN SER LEU LEU THR LYS ASN LYS ALA ARG VAL ILE ILE SEQRES 11 A 458 LEU MET VAL TRP ILE VAL SER GLY LEU THR SER PHE LEU SEQRES 12 A 458 PRO ILE GLN MET HIS TRP TYR ARG ALA THR HIS GLN GLU SEQRES 13 A 458 ALA ILE ASN CYS TYR ALA GLU GLU THR CYS CYS ASP PHE SEQRES 14 A 458 PHE THR ASN GLN ALA TYR ALA ILE ALA SER SER ILE VAL SEQRES 15 A 458 SER PHE TYR VAL PRO LEU VAL ILE MET VAL PHE VAL TYR SEQRES 16 A 458 SER ARG VAL PHE GLN GLU ALA LYS ARG GLN LEU ASN ILE SEQRES 17 A 458 PHE GLU MET LEU ARG ILE ASP GLU GLY LEU ARG LEU LYS SEQRES 18 A 458 ILE TYR LYS ASP THR GLU GLY TYR TYR THR ILE GLY ILE SEQRES 19 A 458 GLY HIS LEU LEU THR LYS SER PRO SER LEU ASN ALA ALA SEQRES 20 A 458 LYS SER GLU LEU ASP LYS ALA ILE GLY ARG ASN THR ASN SEQRES 21 A 458 GLY VAL ILE THR LYS ASP GLU ALA GLU LYS LEU PHE ASN SEQRES 22 A 458 GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG ASN SEQRES 23 A 458 ALA LYS LEU LYS PRO VAL TYR ASP SER LEU ASP ALA VAL SEQRES 24 A 458 ARG ARG ALA ALA LEU ILE ASN MET VAL PHE GLN MET GLY SEQRES 25 A 458 GLU THR GLY VAL ALA GLY PHE THR ASN SER LEU ARG MET SEQRES 26 A 458 LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN LEU SEQRES 27 A 458 ALA LYS SER ARG TRP TYR ASN GLN THR PRO ASN ARG ALA SEQRES 28 A 458 LYS ARG VAL ILE THR THR PHE ARG THR GLY THR TRP ASP SEQRES 29 A 458 ALA TYR LYS PHE CYS LEU LYS GLU HIS LYS ALA LEU LYS SEQRES 30 A 458 THR LEU GLY ILE ILE MET GLY THR PHE THR LEU CYS TRP SEQRES 31 A 458 LEU PRO PHE PHE ILE VAL ASN ILE VAL HIS VAL ILE GLN SEQRES 32 A 458 ASP ASN LEU ILE ARG LYS GLU VAL TYR ILE LEU LEU ASN SEQRES 33 A 458 TRP ILE GLY TYR VAL ASN SER GLY PHE ASN PRO LEU ILE SEQRES 34 A 458 TYR CYS ARG SER PRO ASP PHE ARG ILE ALA PHE GLN GLU SEQRES 35 A 458 LEU LEU CYS LEU ARG ARG SER SER LEU LYS HIS HIS HIS SEQRES 36 A 458 HIS HIS HIS HET ERC A1201 31 HET CLR A1202 28 HET SO4 A1203 5 HET SO4 A1204 5 HET SO4 A1205 5 HET SO4 A1206 5 HET SO4 A1207 5 HET SO4 A1208 5 HETNAM ERC 8-HYDROXY-5-[(1R)-1-HYDROXY-2-({2-[3-METHOXY-4-(3- HETNAM 2 ERC SULFANYLPROPOXY)PHENYL]ETHYL}AMINO)ETHYL]QUINOLIN- HETNAM 3 ERC 2(1H)-ONE HETNAM CLR CHOLESTEROL HETNAM SO4 SULFATE ION FORMUL 2 ERC C23 H28 N2 O5 S FORMUL 3 CLR C27 H46 O FORMUL 4 SO4 6(O4 S 2-) HELIX 1 1 VAL A 31 PHE A 61 1 31 HELIX 2 2 GLU A 62 GLN A 65 5 4 HELIX 3 3 THR A 66 VAL A 86 1 21 HELIX 4 4 VAL A 86 MET A 96 1 11 HELIX 5 5 GLY A 102 THR A 136 1 35 HELIX 6 6 THR A 146 SER A 165 1 20 HELIX 7 7 SER A 165 MET A 171 1 7 HELIX 8 8 HIS A 178 GLU A 187 1 10 HELIX 9 9 ASN A 196 VAL A 206 1 11 HELIX 10 10 PHE A 208 GLN A 229 1 22 HELIX 11 11 ASN A 1002 GLU A 1011 1 10 HELIX 12 12 SER A 1038 GLY A 1051 1 14 HELIX 13 13 THR A 1059 ASN A 1081 1 23 HELIX 14 14 LYS A 1083 ASP A 1089 1 7 HELIX 15 15 ASP A 1092 GLY A 1107 1 16 HELIX 16 16 GLY A 1107 GLY A 1113 1 7 HELIX 17 17 PHE A 1114 GLN A 1123 1 10 HELIX 18 18 ARG A 1125 LYS A 1135 1 11 HELIX 19 19 SER A 1136 THR A 1142 1 7 HELIX 20 20 THR A 1142 GLY A 1156 1 15 HELIX 21 21 TRP A 1158 LYS A 263 5 5 HELIX 22 22 LEU A 266 ILE A 294 1 29 HELIX 23 23 ILE A 294 GLN A 299 1 6 HELIX 24 24 ARG A 304 ASN A 318 1 15 HELIX 25 25 PHE A 321 TYR A 326 1 6 HELIX 26 26 SER A 329 CYS A 341 1 13 SHEET 1 A 3 ARG A1014 LYS A1019 0 SHEET 2 A 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 A 3 HIS A1031 THR A1034 -1 O LEU A1033 N TYR A1025 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.03 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.04 LINK SG CYS A 93 S1 ERC A1201 1555 1555 2.00 SITE 1 AC1 21 GLY A 90 CYS A 93 TRP A 99 TRP A 109 SITE 2 AC1 21 ASP A 113 VAL A 114 CYS A 191 ASP A 192 SITE 3 AC1 21 PHE A 193 ALA A 200 SER A 203 SER A 207 SITE 4 AC1 21 TRP A 286 PHE A 289 PHE A 290 ASN A 293 SITE 5 AC1 21 TYR A 308 ILE A 309 ASN A 312 TRP A 313 SITE 6 AC1 21 TYR A 316 SITE 1 AC2 7 GLN A 65 TYR A 70 THR A 73 CYS A 77 SITE 2 AC2 7 ILE A 154 LEU A 155 TRP A 158 SITE 1 AC3 6 THR A 66 VAL A 67 THR A 68 ARG A 131 SITE 2 AC3 6 TYR A 141 SER A 143 SITE 1 AC4 4 PHE A 264 LYS A 270 LYS A 273 ARG A 328 SITE 1 AC5 3 THR A 146 LYS A 147 ASN A1040 SITE 1 AC6 5 PHE A1114 THR A1115 ASN A1116 SER A1117 SITE 2 AC6 5 ASN A1132 SITE 1 AC7 4 THR A1142 PRO A1143 ASN A1144 ARG A1145 SITE 1 AC8 4 ASP A1092 ALA A1093 ARG A1096 ARG A1119 CRYST1 282.440 40.040 65.210 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.003541 0.000000 0.000000 0.00000 SCALE2 0.000000 0.024975 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015335 0.00000